SLC7A5 and cancer: The well-documented overexpression of some membrane transporters, above described (see Glutamine Supply to Cancer Cells; Table 1), boosted the research of potent and specific inhibitors; in particular, several reports dealt with the identification of inhibitors for ASCT2 (91) and LAT1 (92) via bioinformatics.